World's Best Scientists 2026 revealed!
Lawrence H. Schwartz

Lawrence H. Schwartz

D-Index & Metrics

Medicine

D-Index
119
Citations
106067
World Ranking
3798
National Ranking
2084

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Lawrence H. Schwartz is affiliated with Columbia University in the United States. Their research spans primarily within the field of Medicine, with a strong emphasis on Radiology, Nuclear Medicine, and Imaging among other subfields.

The scientist has contributed extensively to oncology-related topics, especially within the domains of Radiomics and Machine Learning in Medical Imaging, Cancer Immunotherapy and Biomarkers, and Medical Imaging Techniques and Applications. Other highlighted topics in their work include Advanced X-ray and CT Imaging, Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, and Cancer Genomics and Diagnostics.

Notable recent papers authored or co-authored by Lawrence H. Schwartz include:

  • Identification of Non-Small Cell Lung Cancer Sensitive to Systemic Cancer Therapies Using Radiomics, 2020, Clinical Cancer Research
  • Radiomics Response Signature for Identification of Metastatic Colorectal Cancer Sensitive to Therapies Targeting EGFR Pathway, 2020, JNCI Journal of the National Cancer Institute
  • Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX plus hypofractionated radiation therapy (RT) for borderline resectable (BR) adenocarcinoma of the pancreas., 2021, Journal of Clinical Oncology
  • Artificial Intelligence and Early Detection of Pancreatic Cancer, 2021, Pancreas
  • Toward Generalizability in the Deployment of Artificial Intelligence in Radiology: Role of Computation Stress Testing to Overcome Underspecification, 2021, Radiology Artificial Intelligence

Frequent collaborators with Lawrence H. Schwartz include:

  • Laurent Dercle
  • Binsheng Zhao
  • Hao Yang
  • Lin Lü
  • Susan E. Bates

The scientist's work is commonly published in several prominent venues, with a significant number of papers in:

  • Journal of Clinical Oncology
  • European Radiology
  • Blood
  • Tomography
  • Journal for ImmunoTherapy of Cancer

Lawrence H. Schwartz's research intersects multiple medical disciplines, focusing on the applications of advanced imaging technologies and artificial intelligence in cancer diagnosis, treatment strategies, and biomarker identification. Their contributions cover substantial ground in imaging science as it applies to oncology and respiratory medicine.

They have been recognized as a Member of the Association of American Physicians.

Best Publications

  • New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

    Elizabeth Eisenhauer;Patrick Therasse;Jan Bogaerts;L.H. Schwartz

  • The Multimodal Brain Tumor Image Segmentation Benchmark (BRATS)

    Bjoern H. Menze;Andras Jakab;Stefan Bauer;Jayashree Kalpathy-Cramer

  • Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification

    Bruce D. Cheson;Richard I. Fisher;Sally F. Barrington;Franco Cavalli

  • The Lung Image Database Consortium (LIDC) and Image Database Resource Initiative (IDRI): a completed reference database of lung nodules on CT scans.

    Samuel G. Armato;Geoffrey McLennan;Luc Bidaut;Michael F. McNitt-Gray

  • Artificial intelligence in radiology

    Ahmed Hosny;Chintan Parmar;John Quackenbush;Lawrence H. Schwartz;Lawrence H. Schwartz

  • iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics

    Lesley Seymour;Jan Bogaerts;Andrea Perrone;Robert Ford

  • Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma

    Malik E. Juweid;Sigrid Stroobants;Otto S. Hoekstra;Felix M. Mottaghy

  • Phase II Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma

    Ghassan K. Abou-Alfa;Lawrence Schwartz;Sergio Ricci;Dino Amadori

  • RECIST 1.1—Update and clarification: From the RECIST committee

    Lawrence H. Schwartz;Lawrence H. Schwartz;Saskia Litiere;Elisabeth G. E. de Vries;Robert Ford

  • Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by Immunohistochemistry

    Ki Young Chung;Jinru Shia;Nancy E. Kemeny;Manish Shah

  • Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

    Howard I. Scher;Michael J. Morris;Walter M. Stadler;Celestia Higano

  • Phase I Study of an Oral Histone Deacetylase Inhibitor, Suberoylanilide Hydroxamic Acid, in Patients With Advanced Cancer

    William Kevin Kelly;Owen A. O'Connor;Lee M. Krug;Judy H. Chiao

  • Artificial intelligence in cancer imaging: Clinical challenges and applications.

    Wenya Linda Bi;Ahmed Hosny;Matthew B. Schabath;Maryellen L. Giger

  • Prognostic Factors for Survival in Previously Treated Patients With Metastatic Renal Cell Carcinoma

    Robert J. Motzer;Jennifer Bacik;Lawrence H. Schwartz;Victor Reuter

  • Phase I clinical trial of histone deacetylase inhibitor: Suberoylanilide hydroxamic acid administered intravenously

    Wm. Kevin Kelly;Wm. Kevin Kelly;Victoria M. Richon;Owen O’Connor;Tracy Curley

  • Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection.

    Itaru Endo;Mithat Gonen;Adam C. Yopp;Kimberly M. Dalal

  • Deep inspiration breath-hold technique for lung tumors: the potential value of target immobilization and reduced lung density in dose escalation ☆

    Joseph Hanley;Marc M. Debois;Dennis Mah;Gikas S. Mageras

  • Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer

    Daniel C. Danila;Glenn Heller;Gretchen A. Gignac;Rita Gonzalez-Espinoza

  • Phase II Study of Sorafenib in Patients With Metastatic or Recurrent Sarcomas

    Robert G. Maki;David R. D'Adamo;Mary L. Keohan;Michael Saulle

  • NCCN clinical practice guidelines in oncology: kidney cancer.

    Robert J Motzer;Neeraj Agarwal;Clair Beard;Graeme B Bolger

Frequent Co-Authors

Yuman Fong
Yuman Fong City Of Hope National Medical Center
Mithat Gonen
Mithat Gonen Memorial Sloan Kettering Cancer Center
William R. Jarnagin
William R. Jarnagin Memorial Sloan Kettering Cancer Center
Mark G. Kris
Mark G. Kris Memorial Sloan Kettering Cancer Center
Michael I. D’Angelica
Michael I. D’Angelica Memorial Sloan Kettering Cancer Center
Hedvig Hricak
Hedvig Hricak Memorial Sloan Kettering Cancer Center
Ghassan K. Abou-Alfa
Ghassan K. Abou-Alfa Memorial Sloan Kettering Cancer Center
Eileen M. O’Reilly
Eileen M. O’Reilly Memorial Sloan Kettering Cancer Center
Ronald P. DeMatteo
Ronald P. DeMatteo University of Pennsylvania
Michael J. Morris
Michael J. Morris Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in healthcare doesn’t always mean attending medical school. Many students consider direct entry msn programs as a fast track for non-nurses to enter advanced practice nursing without a prior nursing degree. This option is ideal for those who hold a bachelor’s degree in a different field and wish to make a career change.

If you’re looking for accessible pathways, online adn programs allow students to pursue an Associate Degree in Nursing remotely, making it easier for busy adults to start their nursing journey.

For those interested in non-clinical roles, there are reputable medical billing and coding financial aid programs that support students pursuing certificates or degrees in medical administration from accredited online schools.

Furthermore, some nursing schools that don't require teas or hesi exams can help streamline the application process, removing extra testing barriers for prospective students.

These flexible online education options open various career pathways in healthcare, catering to diverse backgrounds and interests.

Best Scientists Citing Lawrence H. Schwartz

Trending Scientists